Hyperhomocysteinemia decreases bone blood flow
Authors:
- Tyagi NeetuTNTyagi Neetu
- Thomas VacekTVThomas Vacek
- Jonathan C. VacekJVJonathan C. Vacek
- Suresh TyagiSTSuresh Tyagi
- John T. FlemingJFJohn T. Fleming
Open Access
- 1 January 2011
- journal article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 7, 31-35
Abstract
Elevated plasma levels of homocysteine (Hcy), known as hyperhomocysteinemia (HHcy), are associated with osteoporosis. A decrease in bone blood flow is a potential cause of compromised bone mechanical properties. Therefore, we hypothesized that HHcy decreases bone blood flow and biomechanical properties. To test this hypothesis, male Sprague–Dawley rats were treated with Hcy (0.67 g/L) in drinking water for 8 weeks. Age-matched rats served as controls. At the end of the treatment period, the rats were anesthetized. Blood samples were collected from experimental or control rats. Biochemical turnover markers (body weight, Hcy, vitamin B12, and folate) were measured. Systolic blood pressure was measured from the right carotid artery. Tibia blood flow was measured by laser Doppler flow probe. The results indicated that Hcy levels were significantly higher in the Hcy-treated group than in control rats, whereas vitamin B12 levels were lower in the Hcy-treated group compared with control rats. There was no significant difference in folate concentration and blood pressure in Hcy-treated versus control rats. The tibial blood flow index of the control group was significantly higher (0.78 ± 0.09 flow unit) compared with the Hcy-treated group (0.51 ± 0.09). The tibial mass was 1.1 ± 0.1 g in the control group and 0.9 ± 0.1 in the Hcy-treated group. The tibia bone density was unchanged in Hcy-treated rats. These results suggest that Hcy causes a reduction in bone blood flow, which contributes to compromised bone biomechanical properties.Keywords
This publication has 25 references indexed in Scilit:
- Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS−/−, and iNOS−/− miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Homocysteine decreases blood flow to the brain due to vascular resistance in carotid arteryNeurochemistry International, 2008
- Oxidative stress, free radicals and bone remodelingClinical Chemistry and Laboratory Medicine (CCLM), 2008
- Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymesBMC Musculoskeletal Disorders, 2007
- Experimental hyperhomocysteinemia disturbs bone metabolism in ratsScandinavian Journal of Clinical and Laboratory Investigation, 2007
- Higher Plasma Homocysteine Concentration Is Associated with More Advanced Systemic Arterial Stiffness and Greater Blood Pressure Response to Stress in Hypertensive PatientsHypertension Research, 2006
- Bone Blood Flow and Vascular ReactivityCells Tissues Organs, 2001
- Biomechanics of Fracture: Is Bone Mineral Density Sufficient to Assess Risk?Journal of Bone and Mineral Research, 2000
- Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine β-synthase-deficient miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Corticosteroids and Fractures: A Close Encounter of the Third Cell KindJournal of Bone and Mineral Research, 2000